We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Igraine Plc - Grant of Investment Rights Over GEM, Conditional Loan Facility with Vela Technologies, Appointment of Executive Director and Proposed Issuance of Equity PR Newswire LONDON, United...
Igraine Plc - Interim Results to 30 June 2024 and Investee: Oscillate Plc posting of circular to approve acquisition PR Newswire LONDON, United Kingdom, September 24 THE DIRECTORS OF IGRAINE PLC...
Igraine Plc - Fixit Medical Ltd Receipt of Grant from Innovate UK PR Newswire LONDON, United Kingdom, July 03 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO...
Igraine Plc - Financial Statements to 31 December 2023 PR Newswire LONDON, United Kingdom, June 25 Financial Statements for the Year Ended 31 December 2023 Igraine Plc(“Igraine” or “the...
don-based healthcare and life-science investor - Says Fixit Medical Ltd has "made significant progress" towards commer ...
G THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED...
The following is a round-up of earnings by London-listed companies, issued last week and not separately reported by A ...
G The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The...
G Igraine plc (AQSE:KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, has received 2 TR-1 Forms, which are...
G 30 June 2023 Igraine Plc AQSE: KING ("Igraine" or "the Company") Audited Financial Statements for the Year Ended 31 December 2022 The full audited annual report can be found...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.275 | 0.2 | 0 | 0 | DE |
4 | 0 | 0 | 0.25 | 0.3314 | 0.2 | 5667 | 0.25 | DE |
12 | -0.025 | -9.09090909091 | 0.275 | 0.3314 | 0.15 | 25965 | 0.24176986 | DE |
26 | -0.05 | -16.6666666667 | 0.3 | 0.35 | 0.101 | 15995 | 0.25032029 | DE |
52 | -0.05 | -16.6666666667 | 0.3 | 0.35 | 0.101 | 9681 | 0.25845893 | DE |
156 | -2.25 | -90 | 2.5 | 2.5 | 0.05 | 79712 | 1.17241094 | DE |
260 | -2.125 | -89.4736842105 | 2.375 | 2.5 | 0.05 | 77664 | 1.24289571 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions